Figure 1: (A) Overview of spermatogenesis and fibrous body-membranous organelle (FB-MO) development. (Top) Spermatocytes develop on a syncytial rachis then detach to undergo the meiotic divisions. Following anaphase II, components which are no longer needed partition to a central residual body (RB). (Bottom) Within meiotic prophase spermatocytes, fibrous bodies (FBs) develop on the cytosolic face of the Golgi-derived membranous organelle (MO). During the budding division, FB-MO complexes partition to the spermatids. MOs then dock with the plasma membrane as the FBs disassemble and release MSP (Major Sperm Protein) dimers into the cytosol. During sperm activation, MSP localizes to the pseudopod, and MOs fuse with the plasma membrane. (B) Alignment of C. elegans ZK265.3/NSPH-2 (Nematode Specific Peptide family, group H) and C04G2.9/NSPH-3.2 with Ascaris MFP2 (MSP Fiber Protein) performed using the EMBL-EBI Clustal Omega Multiple Sequence Alignment tool (Madeira et al., 2019). Peptide for the anti-NSPH-2 antibody is underlined. (C-D) DAPI and anti-NSPH-2 labelling in hermaphrodites with genetic knockouts of
nsph-3.2 and
nsph-2 respectively. (C) Left to right developmental sequence of developing spermatocytes and spermatids. (D) Hermaphrodite spermatozoa within spermatheca. No primary antibody controls were performed on
nsph-3.2 knockout animals. (E-G) Sperm spreads and individually staged cells with (E) anti-MSP labelling (n=63, 9 experiments), (F) anti-NSPH-2 labelling (n=50, 7 experiments), and (G) labelling against the MFP1 homolog, MSD-1 (Major Sperm protein Domain containing) (n=46, 3 experiments). (H-I) Co-labelling of MSP with either (H) anti-NSPH-2 or (I) anti-MSD-1. In spermatozoa (enlarged), the patterns were either fully (top) or partially overlapping (bottom). For NSPH-2/MSP n=16; for MSD-1/MSP n=14. Scale bars = 10 mm for C, D and E-G left; 5 mm for H, I and E-G right. Abbreviations: Karyosome spermatocytes (K), Metaphase spermatocytes (M), Budding Figures (B), Spermatids (S), and Spermatozoa (Z).